SEATTLE–(BUSINESS WIRE)–Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, and The University of Manchester, UK (“UoM”), announced today an exclusive license agreement whereby Acucela will develop and commercialize UoM’s human rhodopsin based optogenetic gene therapy1 for the treatment of retinal degenerative disease, includi
LEXINGTON, Mass.–(BUSINESS WIRE)–J. Martin Carroll has been elected to Inotek’s Board of Directors and has been elected Chairperson of the Board effective as of the 2016 Annual Meeting. Mr. Carroll will succeed Karabelas, Ph.D.
Older adults’ use of prescription medications and dietary supplements, and their concurrent use of interacting medications, has increased, according to recently published findings.These increases put older adults at risk for adverse drug events, Dima M…
CHATTANOOGA, Tenn.–(BUSINESS WIRE)–Unum is acquiring Starmount Life Insurance Company, a leading independent dental and vision benefits company, to expand Unum’s growing portfolio of workplace financial protection benefits.
New data from the VA Diabetes Trial (VADT) reveal some “interesting interactions” between intensive glucose control and lipids in relationship to progression of diabetic retinopathy, researchers say.
Reuters Health Information
This new review gives us an overview of the latest updates in trabeculectomy, and discusses its current role in the management of glaucoma. Current Opinion in Ophthalmology